Selected article for: "median time and symptom onset"

Author: Hao Zhou; Wanxin Chen; Ziping Li; Bohan Yang; Qiong Zhou; Ping Wang; Jianhua Zhu; Xuexing Chen; Peng Yang
Title: Delayed-Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID-19)
  • Document date: 2020_4_15
  • ID: 2my86ums_57
    Snippet: Meanwhile, doctors need to pay attention to the delayed-phase thrombocytopenia especially at 3-4 weeks after symptom onset, which is the median time for delayed-phase thrombocytopenia occurrence. This knowledge may help doctors to timely apply immunoregulatory treatment, and thus improve outcomes. IgG production curve. B. The variation tendency of ten representative patients without delayed-phase thrombocytopenia......
    Document: Meanwhile, doctors need to pay attention to the delayed-phase thrombocytopenia especially at 3-4 weeks after symptom onset, which is the median time for delayed-phase thrombocytopenia occurrence. This knowledge may help doctors to timely apply immunoregulatory treatment, and thus improve outcomes. IgG production curve. B. The variation tendency of ten representative patients without delayed-phase thrombocytopenia.

    Search related documents:
    Co phrase search for related documents
    • attention pay and immunoregulatory treatment: 1
    • attention pay and median time: 1, 2
    • attention pay and outcome improve: 1
    • attention pay and symptom onset: 1, 2, 3, 4, 5, 6
    • delay phase and median time: 1, 2, 3
    • delay phase and symptom onset: 1, 2
    • IgG production and median time: 1
    • IgG production and symptom onset: 1, 2, 3, 4, 5, 6
    • immunoregulatory treatment and symptom onset: 1
    • median time and outcome improve: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • median time and symptom onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • outcome improve and symptom onset: 1, 2, 3, 4
    • representative patient and symptom onset: 1
    • symptom onset and variation tendency: 1, 2, 3